Masthead small

Advocacy Efforts for MFMs & Their Patients

SMFM's Health Policy and Advocacy Committee has been leading efforts to ensure that pregnant women have access to MFMs and are included in COVID-related research efforts. Learn more about our advocacy efforts below. If you have questions or need assistance, contact Rebecca Abbott.

Prioritize and Strengthen the Investment in Research in Pregnant Women 

  • July 10, 2020: SMFM joins a number of national public health organizations to write to Sec. Azar urging him to renew the current public health emergency declaration in order to increase the pace of COVID-19 research and assist states and localities as they respond to outbreaks.

  • July 1, 2020: SMFM joins 350 organizations in a letter to HHS Secretary Alex Azar urging him to affirm the critical role of CDC during the COVID-19 crisis and resist efforts that would undermine its mission.  
  • April 7, 2020: SMFM joins a number of national and state organizations to write to House and Senate leadership urging them to include the Vaccine Awareness Campaign to Champion Immunization Nationally and Enhance Safety (VACCINES) Act of 2019, (H.R. 2862), in the next legislative vehicle to respond to the coronavirus crisis.
  • April 6, 2020: SMFM and ACOG issued a joint statement regarding the CDC's recent removal of pregnant people from their webpage that outlines “people who are at higher risk for severe illness” from COVID-19." 

Ensure that High-Risk Pregnant Women Have Access to Care

Protect Reproductive Rights

  • April 20, 2020: SMFM and ACOG wrote to the FDA urging them to expand its recent policy to apply to the REMS and Elements to Assure Safe Use requirements for certain drugs requiring in-person dispensation, especially mifepristone.

  • April 14, 2020: SMFM signed on to an Amicus Brief for the 10th circuit on Oklahoma’s recent abortion ban.  

Updated December 10, 2020

Find an MFM Specialist